Cooper Companies Inc (COO) Peer Comparison
$60.24
As on 19-Nov-2026 14:40EST
Market cap
$11,913 Mln
Revenue (TTM)
$4,237 Mln
P/E Ratio
21.4
P/B Ratio
1.4
Div. Yield
0 %
| Cooper Companies Inc (COO) | Medtronic PLC (MDT) | Becton Dickinson and Company (BDX) | Veeva Systems Inc. Class A (VEEV) | Agilent Technologies (A) | |
|---|---|---|---|---|---|
Market cap ($ Mln) |
11,913 | 129,180 | 58,757 | 48,964 | 49,051 |
Revenue ($ Mln) |
4,237 | 37,542 | 19,457 | 3,458 | 7,372 |
Net Profit ($ Mln) |
570.30 | 5,230.00 | 1,146.00 | 1,014.77 | 1,440.00 |
Net Margin (%) |
13.46 | 13.93 | 5.66 | 29.34 | 19.53 |
RoE (%) |
6.83 | 10.47 | 4.58 | 13.86 | 20.18 |
Price to Earnings |
21.38 | 24.81 | 42.63 | 49.58 | 34.11 |
Price-To-Book |
1.42 | 2.59 | 2.37 | 6.64 | 6.62 |
Income Statement ($ Mln)
| Cooper Companies Inc (COO) | Medtronic PLC (MDT) | Becton Dickinson and Company (BDX) | Veeva Systems Inc. Class A (VEEV) | Agilent Technologies (A) | |
|---|---|---|---|---|---|
|
Operating Revenue
|
4,092.40 | 33,537.00 | 20,223.00 | 2,746.62 | 6,948.00 |
|
Cost of Revenue
|
1,609.50 | 11,632.00 | 10,717.00 | 699.64 | 3,305.00 |
|
Gross Profit
|
2,482.90 | 21,905.00 | 9,924.00 | 2,046.98 | 3,643.00 |
|
Operating Expenses
|
1,800.00 | 15,950.00 | 7,124.00 | 1,355.55 | 2,164.00 |
|
Operating Profit (EBIT)
|
682.90 | 5,955.00 | 2,383.00 | 691.44 | 1,479.00 |
|
Other Income
|
-- | -- | 0.00 | -- | -- |
|
Profit before Tax
|
566.50 | 5,628.00 | 1,981.00 | 919.38 | 1,435.00 |
|
Provision for Tax
|
191.60 | 936.00 | 493.00 | 205.24 | 132.00 |
|
Profit after Tax (Net Income)
|
374.90 | 4,662.00 | 1,144.00 | 714.14 | 1,303.00 |
|
Minority Interest
|
0.20 | 232.00 | 0.00 | -- | -- |
|
Consolidated Profit
|
-- | 4,662.00 | 382.00 | -- | 1,303.00 |
Liabilities ($ Mln)
| Cooper Companies Inc (COO) | Medtronic PLC (MDT) | Becton Dickinson and Company (BDX) | Veeva Systems Inc. Class A (VEEV) | Agilent Technologies (A) | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
8,238.90 | 48,024.00 | 24,682.00 | 5,832.37 | 6,741.00 |
|
Minority Interest
|
0.20 | 232.00 | 0.00 | -- | -- |
|
Non-Current Liabilities
|
3,042.90 | 30,545.00 | 16,566.00 | 108.98 | 3,639.00 |
|
Current Liabilities
|
1,112.80 | 12,879.00 | 9,543.00 | 1,398.40 | 2,347.00 |
|
Total Liabilities
|
12,394.80 | 91,680.00 | 55,325.00 | 7,339.76 | 12,727.00 |
Assets ($ Mln)
| Cooper Companies Inc (COO) | Medtronic PLC (MDT) | Becton Dickinson and Company (BDX) | Veeva Systems Inc. Class A (VEEV) | Agilent Technologies (A) | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
10,288.40 | 67,865.00 | 42,474.00 | 1,030.95 | 8,133.00 |
|
Current Assets
|
2,106.40 | 23,814.00 | 8,316.00 | 6,308.80 | 4,594.00 |
|
Total Assets
|
12,394.80 | 91,680.00 | 55,325.00 | 7,339.76 | 12,727.00 |
|
Total Debt*
|
2,783.60 | 28,516.00 | 16,345.00 | 75.78 | 3,354.00 |
|
Net Current Assets
|
993.60 | 10,935.00 | 0.00 | 4,910.40 | 2,247.00 |
Cashflow ($ Mln)
| Cooper Companies Inc (COO) | Medtronic PLC (MDT) | Becton Dickinson and Company (BDX) | Veeva Systems Inc. Class A (VEEV) | Agilent Technologies (A) | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
796.10 | 7,044.00 | 3,430.00 | 1,090.05 | 1,559.00 |
|
Cash Flow from Investing Activities
|
-372.90 | -1,937.00 | -818.00 | -700.14 | -394.00 |
|
Cash from Financing Activities
|
-425.90 | -4,361.00 | -3,617.00 | 26.12 | -715.00 |
|
Net Cash Inflow / Outflow
|
-- | -- | -- | -- | -- |
Ratios
Profitability Ratios
| Cooper Companies Inc (COO) | Medtronic PLC (MDT) | Becton Dickinson and Company (BDX) | Veeva Systems Inc. Class A (VEEV) | Agilent Technologies (A) | |
|---|---|---|---|---|---|
|
ROCE (%)
|
3.46 | 6.14 | 3.65 | 13.46 | 13.32 |
|
ROE (%)
|
4.59 | 9.49 | 4.69 | 13.63 | 20.62 |
|
ROA (%)
|
3.03 | 5.13 | 1.86 | 10.78 | 10.61 |
|
EBIT Margin (%)
|
-- | -- | 12.36 | -- | -- |
|
Net Margin (%)
|
9.16 | 13.90 | 5.66 | 26.00 | 18.75 |
|
Cash Profit Margin (%)
|
-- | -- | 0.00 | -- | -- |
Growth Ratios
| Cooper Companies Inc (COO) | Medtronic PLC (MDT) | Becton Dickinson and Company (BDX) | Veeva Systems Inc. Class A (VEEV) | Agilent Technologies (A) | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
0.05 | 0.04 | -7.40 | 0.16 | 0.07 |
|
EBIT Growth (%)
|
-- | -- | 0.20 | -- | -- |
|
Net Profit Growth (%)
|
-4.44 | 26.82 | -31.82 | 35.84 | 1.09 |
|
EPS Growth (%)
|
-- | -- | -28.76 | -- | -- |
|
Book Value Growth (%)
|
-- | -- | 1.85 | -- | -- |
Valuation Ratios
| Cooper Companies Inc (COO) | Medtronic PLC (MDT) | Becton Dickinson and Company (BDX) | Veeva Systems Inc. Class A (VEEV) | Agilent Technologies (A) | |
|---|---|---|---|---|---|
|
Price / Earnings
|
-- | -- | 32.03 | -- | -- |
|
Price / Book Value
|
-- | -- | 2.12 | -- | -- |
|
Dividend Yield (%)
|
-- | -- | -- | -- | -- |
|
EV/EBITDA
|
2.54 | 2.12 | 14.54 | -5.29 | 0.85 |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- | -- |
Solvency Ratios
| Cooper Companies Inc (COO) | Medtronic PLC (MDT) | Becton Dickinson and Company (BDX) | Veeva Systems Inc. Class A (VEEV) | Agilent Technologies (A) | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.34 | 0.59 | 0.00 | 0.01 | 0.50 |
|
Short term debt to equity ratio
|
0.01 | 0.06 | 0.12 | 0.00 | 0.05 |
|
Current Ratio
|
1.89 | 1.85 | 0.87 | 4.51 | 1.96 |
|
Quick Ratio
|
1.13 | 1.42 | 0.54 | -- | 1.52 |
|
Interest Coverage
|
6.30 | 8.72 | 4.82 | -- | 13.81 |
Operating Efficiency Ratios
| Cooper Companies Inc (COO) | Medtronic PLC (MDT) | Becton Dickinson and Company (BDX) | Veeva Systems Inc. Class A (VEEV) | Agilent Technologies (A) | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
20.26 | 19.43 | 13.70 | 38.49 | 21.40 |
|
Asset Turnover
|
0.33 | 0.37 | 0.33 | 0.41 | 0.57 |
|
Receivable days
|
68.99 | 68.85 | 50.40 | 129.37 | 73.89 |
|
Inventory Days
|
187.07 | 167.88 | 118.59 | 0.00 | 111.40 |
|
Payable days
|
63.64 | 76.29 | 59.32 | 16.17 | 61.34 |
|
Cash Conversion Cycle
|
192.42 | 160.44 | 109.67 | 109.59 | 123.95 |